"Transfusion Reaction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
Descriptor ID |
D065227
|
MeSH Number(s) |
C15.378.962 C20.920
|
Concept/Terms |
Transfusion Reaction- Transfusion Reaction
- Transfusion Reactions
- Blood Transfusion-Associated Adverse Reactions
- Blood Transfusion Associated Adverse Reactions
Hemolytic Transfusion Reaction- Hemolytic Transfusion Reaction
- Hemolytic Transfusion Reactions
- Reaction, Hemolytic Transfusion
- Reactions, Hemolytic Transfusion
- Transfusion Reaction, Hemolytic
- Transfusion Reactions, Hemolytic
Transfusion-Transmitted Infection- Transfusion-Transmitted Infection
- Infection, Transfusion-Transmitted
- Transfusion Transmitted Infection
- Transfusion-Transmitted Infections
Transfusion-Associated Circulatory Overload- Transfusion-Associated Circulatory Overload
- Circulatory Overload, Transfusion-Associated
- Circulatory Overloads, Transfusion-Associated
- Transfusion Associated Circulatory Overload
- Transfusion-Associated Circulatory Overloads
Hypotensive Transfusion Reaction- Hypotensive Transfusion Reaction
- Reaction, Hypotensive Transfusion
- Transfusion Reaction, Hypotensive
- Transfusion Reactions, Hypotensive
|
Below are MeSH descriptors whose meaning is more general than "Transfusion Reaction".
Below are MeSH descriptors whose meaning is more specific than "Transfusion Reaction".
This graph shows the total number of publications written about "Transfusion Reaction" by people in this website by year, and whether "Transfusion Reaction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 1 | 2 | 3 |
1996 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 2 | 1 | 3 |
2004 | 0 | 1 | 1 |
2005 | 2 | 0 | 2 |
2006 | 1 | 1 | 2 |
2008 | 2 | 0 | 2 |
2009 | 4 | 0 | 4 |
2010 | 1 | 1 | 2 |
2011 | 3 | 0 | 3 |
2012 | 0 | 4 | 4 |
2013 | 2 | 4 | 6 |
2014 | 4 | 2 | 6 |
2015 | 2 | 4 | 6 |
2019 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2022 | 3 | 0 | 3 |
2023 | 1 | 0 | 1 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transfusion Reaction" by people in Profiles.
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
-
Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance. Lab Med. 2024 May 02; 55(3):251-254.
-
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. Transfusion. 2023 09; 63(9):1639-1648.
-
Transfusion-Associated Adverse Events: A Case Report of Nurse Hemovigilance and Recognition of Respiratory Distress. J Infus Nurs. 2022 Sep-Oct 01; 45(5):264-269.
-
Oncology Patients Who Develop Transfusion-Associated Circulatory Overload: An Observational Study. Lab Med. 2022 Jul 04; 53(4):344-348.
-
Digitally enabled hemovigilance allows real time response to transfusion reactions. Transfusion. 2022 05; 62(5):1010-1018.
-
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 07; 18(7):435-453.
-
Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17?years' experience in a tertiary center. Transfusion. 2020 11; 60(11):2557-2564.
-
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial. Ann Intern Med. 2020 04 21; 172(8):513-522.
-
Safety incident reports associated with blood transfusions. Transfusion. 2019 09; 59(9):2827-2832.